⌘K
Loading ticker…
As of 2026-08-24, Organon & Co. (OGN) has a 3-month relative strength percentile of 53 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 63. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 0.3%, relative volume 1.81×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
OGN is in a stage 2 uptrend, week 9. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 1.5% / 37.6%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
OGN is held by 31 ETFs as of May 2026. Top owner: SCHA at 0.07% weight, $17M notional. Top 3 carry $45M.
Held by 94 ETFs · $486M across latest filings · largest weight 3.83% (FXH).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| SCHASchwab U.S. Small-Cap ETF | 0.07% | $17M | +0.03 pp |
| RWJ | 0.77% | $14M | +0.35 pp |
| FNDXSchwab Fundamental U.S. Large Company Index ETF | 0.05% | $14M | +0.03 pp |
| VIOOVanguard S&P Small-Cap 600 ETF | 0.20% | $12M | +0.08 pp |
| VHT |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.05% |
| $10M |
| +0.03 pp |
| VIOVVanguard S&P Small-Cap 600 Value ETF | 0.40% | $8M | +0.16 pp |
| AVSC | 0.22% | $6M | +0.05 pp |
| PSCH | 1.85% | $2M | +0.72 pp |
| ARB | 2.29% | $2M | — |
| VONVVanguard Russell 1000 Value ETF | 0.01% | $2M | — |
Showing 10 of 31 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | OGN Jan avg: 11.68% median: 11.67% win: 100% σ: 6.80% n: 4 2022-04-12 → 2026-07-31 | OGN Feb avg: -8.24% median: -9.41% win: 25% σ: 10.51% n: 4 2022-04-12 → 2026-07-31 | OGN Mar avg: -3.49% median: -2.05% win: 25% σ: 10.78% n: 4 2022-04-12 → 2026-07-31 | OGN Apr avg: 20.73% median: -1.01% win: 40% σ: 56.58% n: 5 2022-04-12 → 2026-07-31 | OGN May avg: -3.45% median: 0.68% win: 60% σ: 20.82% n: 5 2022-04-12 → 2026-07-31 | OGN Jun avg: -0.05% median: 1.50% win: 60% σ: 7.29% n: 5 2022-04-12 → 2026-07-31 | OGN Jul avg: 1.10% median: 0.21% win: 80% σ: 4.83% n: 5 2022-04-12 → 2026-07-31 | OGN Aug avg: -2.70% median: -1.49% win: 25% σ: 5.33% n: 4 2022-04-12 → 2026-07-31 (current) | OGN Sep avg: -9.99% median: -16.19% win: 25% σ: 15.80% n: 4 2022-04-12 → 2026-07-31 | OGN Oct avg: -10.39% median: -8.32% win: 25% σ: 20.71% n: 4 2022-04-12 → 2026-07-31 | OGN Nov avg: -6.34% median: -8.05% win: 25% σ: 16.66% n: 4 2022-04-12 → 2026-07-31 | OGN Dec avg: 5.43% median: 0.68% win: 50% σ: 16.03% n: 4 2022-04-12 → 2026-07-31 |